The Irish Thalidomide Association has described a meeting it had with the Taoiseach today as "very constructive".
Survivors are calling for an updated compensation and health package, saying their health is deteriorating.
Finola Cassidy from the Association said the Taoiseach had "really listened" to their concerns.
She says she outlined the need for fair and equitable compensation as well as detailing their growing healthcare needs which are now being exacerbated as survivors are now aged in their sixties.
She said the Taoiseach said he would arrange another meeting in "the very near future".
Thalidomide is a chemical ingredient which was sold under ten different trade names in Ireland from 1957 to alleviate morning sickness.
It was withdrawn internationally in 1961 after it was found to cause major birth defects.
Babies were born with shortened or no limbs and with painful damage to nerves, organs, hearing and eyesight.
There are 40 survivors in Ireland and 4,000 survivors worldwide.
The Association says many of its members are living with daily chronic pain and said many survivors have experienced poor quality care, often in the wrong settings and with undesirable outcomes.